ERS Genomics
ERS Genomics Licenses CRISPR-Cas9 IP to Sumitomo Pharma
The nonexclusive licensing agreement with the Japanese drugmaker marks the 16th such deal ERS Genomics has signed in Japan.
ERS Genomics Licenses CRISPR IP to Central Institute for Experimental Animals
ERS Genomics was founded to provide access to CRISPR-Cas9 intellectual property held by Emmanuelle Charpentier.
ERS Genomics Licenses CRISPR-Cas9 Portfolio to Cellular Engineering Technologies
CET said it will integrate its stem cell technology with CRISPR-Cas9 to create next-generation stem cells for life science research.
ERS Genomics Licenses CRISPR IP to Japan SLC
Japan SLC, a biotechnology company providing animal models to the research community, will use the license to expand its offerings.
Jun 7, 2021
ERS Genomics Licenses CRISPR IP to GenOway
Apr 19, 2021
ERS Genomics Licenses CRISPR Patents to Nuvisan
Mar 10, 2021